P/E ratio for DaVita (DVA)
P/E ratio as of June 2023 (TTM): 17.8
According to DaVita's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 17.7706. At the end of 2021 the company had a P/E ratio of 12.3.
P/E ratio history for DaVita from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 12.3 | -32.76% |
| 2020 | 18.2 | 30.72% |
| 2019 | 13.9 | -77.24% |
| 2018 | 61.3 | 197.62% |
| 2017 | 20.6 | 39.47% |
| 2016 | 14.8 | -73.11% |
| 2015 | 54.9 | 147.85% |
| 2014 | 22.1 | 5.37% |
| 2013 | 21.0 | 5.73% |
| 2012 | 19.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Universal Health Services
UHS | 14.2 | -20.21% | 🇺🇸 USA |
 LabCorp LH | 19.7 | 10.71% | 🇺🇸 USA |
 Tenet Healthcare THC | 18.8 | 5.58% | 🇺🇸 USA |
 Pediatrix Medical Group MD | 11.3 | -36.17% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.